Dr. Hanns Lochmüller Awarded “Researcher of the Year” by University of Ottawa and The Ottawa Hospital Department of Medicine

We are delighted to announce that Hanns is this year’s winner of the Researcher of the Year award conferred by the University of Ottawa/The Ottawa Hospital Department of Medicine. Hanns was nominated by Dr Grant Stotts, head of the Division of Neurology, for his productivity in clinical and basic research, his recognition globally in the neuromuscular field, and his leadership of NMD4C, the neuromuscular network for Canada, which brings together neuromuscular clinicians, researchers and patients across the country.

Hanns receiving the Department of Medicine Researcher of the Year Award on May 30, 2024.

 

The award was conferred as part of the Department of Medicine’s Recognition Ceremony on 30 May 2024, where departmental researchers were honoured for their contributions to research and patient care.

“This award is in recognition of your unparalleled contributions to the field of neuromuscular diseases, your outstanding research achievements, and your leadership within the scientific community.”
Greg Knoll, MD MSc FRCPC,Chair and Head, Department of Medicine

 

Lab members (from left) Dr Alberto Aleman, Dr Sally Spendiff, Dr Hanns Lochmüller, Catherine Choueiri, Stephen Holland, and Ricardo Carmona all attended the award ceremony to celebrate with Hanns.

Several members of the Lochmüller Lab were present to share in the celebrations, which was not only a fitting acknowledgement of the high regard in which Hanns is held within his research group but also underscores the fact that our research is very much a team effort, with our success being very much a result of the close internal and external collaborations that are the cornerstone of Hanns’s research ethos.

 

Congratulations, Hanns! Your team is very proud of you! 

Congratulations Dr Hanns Lochmuller, Department of medicine researcher of the year 2024. Photo of Hanns and lab members receiving the award.

Read next...

award winners

Celebrating Lab Members’ Recent Research Awards

We are thrilled to celebrate Kelly Ho for receiving first place for her poster presentation at this year’s American Society for Pharmacology and Experimental Therapeutics...
New publication - RTD (2)

Meet The Lochmüller Lab’s Newest Members!

Our research team is growing! We are excited to introduce three new members who have recently joined the Lochmüller lab and several students who will...
McMillan smart study (1)

New Clinical Study Examines Safety and Efficacy of IV Onasemnogene Abeparvovec in Broad SMA Cohort

Pediatric neurologist Dr Hugh McMillan publishes clinical study examining the safety and efficacy of IV onasemnogene abeparvovec in the broadest cohort of SMA patients to...
Text reading: Solve-RD publication: Solve-RD flagship publication: Genomic reanalysis of a pan-European rare-disease resource yields new diagnoses. Photos of Dr Kiran Polavarapu, Dr Rachel Thompson, Dr Hanns Lochmüller.

Solve-RD flagship publication in Nature Medicine: Genomic reanalysis of a pan-European rare-disease resource yields new diagnoses

Patients and families with rare disorders often remain without a genetic diagnosis despite modern advances in diagnostic testing. Due to the rarity and global distribution...
New publication: Identifies Novel ATP2A2 Variant as Genetic Cause of Dominant Rhabdomyolysis . Author's photos on the right, diagram from paper underneath title.

New Lab Publication Identifies Novel ATP2A2 Variant as Genetic Cause of Dominant Rhabdomyolysis

Rhabdomyolysis is an acute failure of cellular homeostasis characterized by acute skeletal muscle damage triggered by trauma, infection, drugs, or strenuous exercise. Recurrent rhabdomyolysis is...
New lab publication on riboflavin transporter deficiency model

New Publication: Development of a riboflavin-responsive model of riboflavin transporter deficiency in zebrafish

Riboflavin transporter deficiency (RTD) is a rare genetic disorder in children, characterised by progressive sensorimotor and cranial neuronopathy caused by mutations in riboflavin transporter protein-encoding...